Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Monsanto just keeps it coming...
Monsanto Declares 54-Cent Quarterly Dividend (MON)
"...Shares of Monsanto Company (MON) have steadily risen, climbing as much as 14% in two months on the back of the company's continued operational improvements as well as the recent uptick in the agriculture industry.
With the company now beating Wall Street's top- and bottom-line estimates in two straight quarters, Monsanto management wants to share some of that success with investors. On Friday, the St. Louis-based agriculture giant declared a 54-cent per share cash dividend, payable on April 28 to shareholders of record as of April 7. The stock will trade ex-dividend on April 5. To qualify for the dividend check, investors must own Monsanto shares before April 5, which is the day the company will finalize its roster of shareholders to whom it will mail payments.."
http://www.investopedia.com/news/monsanto-declares-54cent-quarterly-dividend-mon/?partner=YahooSA&yptr=yahoo
GO MON
"PEACE"
Now green and lean waiting on that final monetary dream....$128.00.
GO MON
Monsanto: Analyst Recommendations and Price Target
http://marketrealist.com/2017/01/analysts-price-target-recommendation-monsanto/?utm_source=yahoo&utm_medium=feed&yptr=yahoo
GO MON
"PEACE"
Now green and lean waiting on that final monetary dream....$128.00.
Monsanto, California Battle Over Listing Glyphosate as a Carcinogen
http://www.ecowatch.com/glyphosate-cancer-kennedy-2199066232.html
GO MON
"PEACE"
Now green and lean waiting on that final monetary dream....$128.00.
More Monsanto News to push toward the $128 ending deal.
Bayer to Boost US Jobs, Investments Amid Monsanto Deal: Trump Spokesman
http://www.newsmax.com/Finance/StreetTalk/bayer-monsanto-trump-jobs/2017/01/17/id/768990/
Trump takes credit for saving Monsanto jobs, but ...
"Following Donald Trump's meeting with the CEOs of Monsanto and Bayer last week, the president-elect's transition team says the companies will increase research and development spending in the U.S. and keep Monsanto's headquarters in St. Louis"
.....Incoming White House press secretary Sean Spicer told reporters Tuesday that, after the meeting, the two companies have committed to $8 billion in R&D spending within the U.S.
Spicer added that Monsanto and Bayer pledged to keep all of Monsanto's nearly 10,000 U.S. workers. The companies said they plan to create more than 3,000 high-tech jobs in the United States.......
http://money.cnn.com/2017/01/17/investing/monsanto-bayer-trump-jobs/index.html
GO MON
"PEACE"
Now green and lean waiting on that final monetary dream....$128.00.
Monsanto Co. (MON)
Simple Moving Average (SMA)
MON is trading above its 50 day simple moving average. This is considered to be the sign of a bullish trend. There is added weight to this indication because the moving average is rising and suggests that there has been buying interest in this stock.
Exponential Moving Average (EMA)
MON is trading above its 200 day exponential moving average. This is considered to be the sign of a bullish trend. There is added weight to this indication because the moving average is rising and suggests that there has been buying interest in this stock.
Bollinger Bands ®
MON is within its Bollinger Bands. This is a normal condition suggesting that it is neither overbought nor oversold relative to the recent levels.
Relative Strength Index (RSI)
The RSI recently dropped to 62.50 from above the critical level of 70. This signals that MON is no longer overbought and the internal strength of the stock appears to be waning.
Stochastics
The Stochastic Oscillator is registering a bearish signal as the %K line has crossed under the %D and the oscillator recently crossed below the critical value of 80, moving from its overbought indication.
Moving Average Convergence Divergence(MACD)
The MACD for MON currently indicates a strong bullish signal for two reasons. First, the MACD is above the signal line, a 9-day moving average. Second, the MACD is above 0 which implies that the underlying moving averages are trending higher.
GO MON
"PEACE"
Now green and lean waiting on that final monetary dream....$128.00.
IN MORE MONSANTO NEWS
Bayer, Monsanto CEOs Pitch Deal to Trump
CEOs met with president-elect Wednesday in New York
http://www.wsj.com/articles/bayer-monsanto-ceos-pitch-deal-to-trump-1484166068?mod=yahoo_hs&yptr=yahoo
Monsanto (MON) Upgraded to Buy on Solid Growth Drivers
https://finance.yahoo.com/news/monsanto-mon-upgraded-buy-solid-141502014.html
Monsanto CEO: Feeling positive on Bayer-Monsanto deal
https://finance.yahoo.com/video/monsanto-ceo-feeling-positive-bayer-194000805.html
Monsanto Co. :MON-US: Earnings Analysis: Q1, 2017 By the Numbers : January 10, 2017
http://www.capitalcube.com/blog/index.php/monsanto-co-mon-us-earnings-analysis-q1-2017-by-the-numbers-january-10-2017/?yptr=yahoo
Monsanto’s South American Market Lifts Gross Margins in Fiscal 1Q17
http://marketrealist.com/2017/01/monsantos-south-american-market-lifts-gross-margins-1q17/?utm_source=yahoo&utm_medium=feed&yptr=yahoo
GO MON
"PEACE"
Now green and lean waiting on that final monetary dream....$128.00.
Monsanto swings to profit on higher South America demand
"Chicago (Reuters) - U.S. seeds and agrochemicals company Monsanto Co <MON.N>, which is in the process of being bought by Germany's Bayer AG <BAYGn.DE> for $66 billion, swung to a quarterly profit, helped by higher demand from South America.
Sales of soybean seeds and traits jumped 37 percent as more farmers in South America sowed the company's genetically modified soybean seed Intacta RR2 Pro.
But how Monsanto is navigating through a souring U.S. agricultural market has been closely watched by Bayer's investors, who have backed the German pharmaceutical conglomerate’s bid to acquire the world’s largest seed company.
Monsanto shareholders voted in December to approve a sweetened $128-per-share offer from Bayer that, if approved by regulators, would create a company commanding more than a quarter of the world market for seeds and pesticides and be the largest-ever cash takeover of a U.S. company.
Both companies have filed notice of the merger plan to U.S. antitrust officials and plan to submit similar documents to the European Union by the end of March, Chief Executive Officer Hugh Grant told analysts on a conference call on Thursday for Monsanto's first fiscal 2017 quarterly results."
https://finance.yahoo.com/news/monsanto-swings-quarterly-profit-131507237--finance.html
GO MON
"PEACE"
Now green and lean waiting on that final monetary cream....$128.00.
Monsanto CEO: Bayer buyout on track to close by year's end
"Monsanto CEO Hugh Grant said in an earnings call Thursday that the mega-merger with one of Research Triangle Park’s largest employers, Bayer, remains on track to close by the end of the year. The deal could have a huge impact on North Carolina because Bayer houses about 1,000 employees and multiple agriculture divisions in RTP. “With the [shareholder] vote behind us, our team is working with Bayer on the required regulatory filings and continued key stakeholder outreach,” he said. The companies have made necessary regulatory filings in the United States, with the submission of the required filing in the European Union expected in the first calendar quarter of 2017, according to Grant. He said"
http://www.bizjournals.com/triangle/news/2017/01/05/monsanto-ceo-bayer-buyout-on-track-to-close-by.html?ana=yahoo&yptr=yahoo
GO MON
"PEACE"
Now green and lean waiting on that final monetary cream....$128.00.
MON FY1Q17 items…
Financial slides:
http://www.monsanto.com/investors/Documents/2017/2017.01.05_Q1F17_MON_Financial.pdf
Pipeline slides:
http://www.monsanto.com/investors/Documents/2017/2017.01.05_Q1F17_MON_Pipeline.pdf
MON licenses CRISPR-Cpf1 IP from Broad Institute: #msg-127621988.
To late for the dividend, but MON is still trading well below value,
Monsanto Stock Trades Ex-Dividend Wednesday
"...based on Tuesday's closing price of $105.31, Monsanto's 54-cent per share quarterly dividend yields 2.05% annually, or about 5 basis points above the 2.00% average yield of the S&P 500 index. Monsanto will send its dividend payment on Jan. 27 to shareholders of record as of Jan. 6. The stock has a consensus Hold rating and an average analyst 12-month price target of $119.50, implying a rise of 13.5% from current levels."
http://www.investopedia.com/news/monsanto-stock-trades-exdividend-wednesday-mon/?partner=YahooSA&yptr=yahoo
GO MON
Now green and lean waiting on that final monetary dream....$128.00.
What Drives Monsanto Stock in 2017? (MON, BAYRY)
"The company now forecasts 2017 earnings in the range of $4.50 to $4.90 per share, which suggests year-over-year growth of 9.15%. Monsanto shares are currently priced at a forward P/E ratio of 22 based on fiscal 2017 estimates of $4.72 per share. The P/E puts Monsanto's valuation at about four points above the average stock in the S&P 500 index.
All told, Monsanto stock is not cheap, but with Bayer's $128 per share offer price still on the table, the risk-versus-reward favors owning Monsanto. And with President-elect Donald Trump's pro-business policies set to take effect, which increases the chances of the Bayer deal closing, Monsanto could be a way to grow the value in your portfolio." (See also: Who Are Monsanto's Main Competitors?)
http://www.investopedia.com/news/what-drives-monsanto-stock-2017-mon-bayry/
GO MON
"PEACE"
Now green and lean waiting on that final monetary cream....$128.00.
WE WILL SEE
Monsanto (MON) Q1 Earnings: What's in Store for the Stock?
"Monsanto Company MON is scheduled to report its first-quarter fiscal 2017 (ended Nov 2016) results before the opening bell on Jan 5, 2017.
Post fourth-quarter fiscal 2016 earnings release (Oct 5, 2016), Monsanto’s shares recorded a return of 1.97%, as against the negative return of 1.23% provided by the Zacks categorized Agriculture/Products industry. However, this Zacks Rank #3 (Hold) has witnessed a positive average earnings surprise of 124.52% for the trailing four quarters."
http://finance.yahoo.com/news/monsanto-mon-q1-earnings-whats-124812692.html
GO MON
"PEACE"
Now green and lean waiting on that final monetary cream....$128.00.
For those who don't know..........$0.54 divvy coming up.
STILL NOT TO LATE TO QUALIFY.
Monsanto Declares 54-Cent Cash Dividend (MON)
"Shares of Monsanto Company (MON) might still be trading some 18% below Bayer AG's (BAYRY) $128 per share offer price, but that hasn't stopped the company from honoring its commitment to shareholders.
On Monday, the St. Louis-based agriculture giant declared a 54-cent per share dividend that is payable Jan. 27, 2017, to shareholders of record as of Jan. 6, 2017. The stock will trade ex-dividend on Jan. 4, 2017. To qualify for the dividend check, investors must own Monsanto shares before Jan. 4, which is the day the company will finalize its roster of shareholders to whom it will mail payments."
http://www.investopedia.com/news/monsanto-declares-54cent-cash-dividend-mon/?partner=YahooSA&yptr=yahoo
GO MON
"PEACE"
Now green and lean waiting on that final monetary cream....$128.00.
Read more: Monsanto Declares 54-Cent Cash Dividend (MON) | Investopedia http://www.investopedia.com/news/monsanto-declares-54cent-cash-dividend-mon/#ixzz4UfuKGBZc
MON shareholders approve Bayer acquisition:
http://finance.yahoo.com/news/monsanto-shareowners-approve-merger-bayer-142100319.html
This is the easy part, of course; the harder part of the deal is getting antitrust clearance.
Bayer shareholders will not be voting on the deal.
Washington state sues Monsanto over ‘omnipresent and terrifically toxic material'
RT America Today
9 Dec, 2016 10:59
PCB pollution is in “every waterway in the state,” Washington Attorney General Bob Ferguson said as he announced a lawsuit against Monsanto. It is the first time the agricultural biotech giant has ever been sued by a state.
Polychlorinated biphenyls, or PCBs, have been at the heart of multiple lawsuits brought against the multinational agrochemical corporation Monsanto by Seattle and Spokane, Washington, as well as cities in California and Oregon. However, this Thursday marked the first time a state government has sued the company over the potentially carcinogenic chemicals.
The lawsuit, which seeks monetary restitution for damages and cleanup caused by the use of PCBs, was filed in King County Superior Court. Washington Governor Jay Inslee (D) and the state’s Attorney General Bob Ferguson jointly announced the lawsuit in a press conference, claiming that Monsanto knew for years that it was polluting bays, lakes and rivers when it used the chemicals in coolants, hydraulic fluids, paints and sealants, Associated Press reported ( http://tinyurl.com/h9k94hr ).
A win for the state could potentially reap hundreds of millions of dollars from Monsanto as well as two subsidiaries, Solutia Inc. and Pharmacia LLC.
Monsanto quit using PCBs when Congress banned them in 1979, but many say the damage had already been done and the chemicals’ impact are still felt today. From 1935 to 1979, Monsanto was the only company to produce PCBs, described by Ferguson as “one of the most pervasive pollutants in history,” the Seattle Post-Intelligencer reported ( http://tinyurl.com/zrq2f87 ).
Inslee called the chemicals “omnipresent and terrifically toxic, adding that “one of the highest recorded (PCB concentrations) for any place on Earth” was in Washington’s southern resident orca population, according to the Post-Intelligencer.
The US Environmental Protection Agency classifies PCBs as a likely human carcinogen that also pose a risk of severe damage to the endocrine, immune, nervous and reproductive systems. Washington state’s Department of Health posted 13 different advisories against fish consumption due to risks of PCB pollution. Seattle’s Duwamish River is an EPA Superfund cleanup site, and one of its hazardous contaminants is PCB.
"Monsanto is responsible for producing a chemical that is so widespread in our environment that it appears virtually everywhere we look – in our waterways, in people and in fish – at levels that can impact our health,” Inslee said at the Thursday press conference, the Post-Intelligencer reported.
During the presser, Ferguson reportedly quoted from an internal Monsanto memo from 1937, which acknowledged lengthy exposure to PCB vapors having “systemic toxic effects.” Ferguson cited other records as well, charging that the corporation hid this sort of information from the public even though it knew of global PCB pollution in the 1960s.
I don't understand your question. Bayer's offer is $128/sh in cash.
MO MONEY, MO MONEY!
https://finance.yahoo.com/m/8d41e554-ec29-3815-a12f-4c49f2753ca7/monsanto-declares-54-cent.html
".......On Monday, the St. Louis-based agriculture giant declared a 54-cent per share dividend that is payable Jan. 27, 2017, to shareholders of record as of Jan. 6, 2017. The stock will trade ex-dividend on Jan. 4, 2017. To qualify for the dividend check, investors must own Monsanto shares before Jan. 4, which is the day the company will finalize its roster of shareholders to whom it will mail payments. (See also: Monsanto's New Seeds Coated With Fungi.)...................."
GO MON
"PEACE"
Now green and lean waiting for more steam.
This company was a clear buy, if one was willing to wager the risk associated with approval, the moment the $68 billion price at $128 a share was announced..........The dips are an opportunity to add more.
The Regulators and Congress approval is all that is holding back share price, and profits to all those holding a position.
GO MON
"PEACE"
$$$ I CAN WAIT $$$.
Time for people to vote and wait for this puppy to pay up.
On the last dip this company was a clear buy that will provide profits to investors.
The defeat of Hillary Clinton just dealt a devastating blow to Monsanto, Big Pharma and the corrupt vaccine industry
http://www.thecommonsenseshow.com/2016/11/10/the-defeat-of-hillary-clinton-just-dealt-a-devastating-blow-to-monsanto-big-pharma-and-the-corrupt-vaccine-industry/
Quote:This is why the Donald Trump victory was so incredibly important for America. Now we have a chance to beat back the big ugly corporate monsters like Monsanto and Merck. With Trump in the White House, we have a legitimate shot at real health care reform, medical freedom and even codifying religious medical freedoms into federal law. It doesn’t mean we can achieve all this, but we have a legitimate shot at meaningful reform that works in our favor. (Trump isn’t God. He can’t wave a magic wand and accomplish everything all at once. He still must work within a rigged system run by lifelong bureaucrats and bribed members of the House and Senate.)
Bayer lines up $56.9B from bank syndicate to fund MON acquisition:
#msg-125752685
Terms have not been disclosed. (The terms presumably won’t be disclosed unless the loans are drawn—i.e. if the MON deal is consummated.)
This is the Monsanto board, not TSLA.
Welcome bump up but I still need my other 3% back. This has not been one of my better moves. Oh well
MON provides FY2017 EPS guidance: #msg-125589978.
I'm pretty sure merger is to finalize toward the end of 2017...so, a ways off, yet.
I am starting to get the feeling this merger is never going to happen The share price just keep going lower I would think if the merger was going to happen this would be moving higher
Monsanto is one of the most desirable companies out there. With drought and an ever increasing population, we need their technology to sustain. MON is a 200b company in 20 years imo.
No chance, IMO. Who could possibly top Bayer's $66B all-cash offer?
The merger agreement states that if mon gets a higher bid for tne co. they can except it
Is there a chance they get a higher offer ?
UPGRADE: Monsanto (MON) upgraded by JP Morgan from Neutral to Overweight.
BRIEFING.COM 10:05 AM ET 9/21/2016
Full terms of Bayer-MON merger:
https://www.sec.gov/Archives/edgar/data/1110783/000119312516714915/d234658dex21.htm
Still a go bet and probably good investment, if you do not necessarily need the money's right now and or don't have any other good investments options at the moment.
A chance to make 25% on your investment dollars, even if you have to hold for a year.
$25k / $102 = 245 X 128 = 31,372 = 25% +/- 1% a yield or approximately $6k in turns........BUY MORE, MAKE MORE...................Not bad, not bad at all.
GO MON
"PEACE"
$$$$$$ I'VE GOT MINE $$$$$$
Wide range of opinions on that. Some sell-side analysts peg probability of deal consummation at 75%; other have it at <50%.
I will be surprised if the Bayer/Mon merger goes through.
Results of my Twitter poll:
https://twitter.com/DewDiligence/status/776567615347011584
Why I vote for "bullish": #msg-125198349.
Monsanto and Bayer: Why Food And Agriculture Just Took A Turn For The Worse
By Colin Todhunter
Global Research
September 15, 2016
(please note: The underlined words are 'clickable' links when accessed via the link at the bottom of this page)
News broke this week that Monsanto accepted a $66 billion takeover bid from Bayer. The new company would control more than 25 per cent of the global supply of commercial seeds and pesticides. Bayer’s crop chemicals business is the world’s second largest after Syngenta, and Monsanto is the leading commercial seeds business.
Monsanto held a 26 per cent market share of all seeds sold in 2011. Bayer (mainly a pharmaceuticals company) sells 17 per cent of the world’s total agrochemicals and also has a comparatively small seeds sector. If competition authorities pass the deal, the combined company would be the globe’s largest seller of both seeds and agrochemicals.
The deal marks a trend towards consolidation in the industry with Dow and DuPont having agreed to merge and Swiss seed/pesticide giant Syngenta merging with ChemChina, a Chinese government concern.
The mergers would mean that three companies would dominate the commercial agricultural seeds and chemicals sector, down from six - Syngenta, Bayer, BASF, Dow, Monsanto and DuPont. Prior to the mergers, these six firms controlled 60 per cent of commercial seed and more than 75 per cent of agrochemical markets.
Alarm bells are ringing with the European Commission putting its approval of the Dow-DuPont deal temporarily on hold, and the US Senate Judiciary Committee is about to hold hearings on the deal due to concerns about consolidation in the industry, which has resulted in increased seed and pesticide prices.
In response to the Monsanto-Bayer merger, US National Farmers Union President Roger Johnson issued the following statement:
“Consolidation of this magnitude cannot be the standard for agriculture, nor should we allow it to determine the landscape for our future. The merger between Bayer and Monsanto marks the fifth major deal in agriculture in the last year… For the last several days, our family farm and ranch members have been on Capitol Hill asking Members of Congress to conduct hearings to review the staggering amount of pending merger deals in agriculture today. We will continue to express concern that these megadeals are being made to benefit the corporate boardrooms at the expense of family farmers, ranchers, consumers and rural economies. We are pleased that next week the Senate Judiciary Committee will be reviewing the alarming trend of consolidation in agriculture that has led to less competition, stifled innovation, higher prices and job loss in rural America… all mergers, including this recent Bayer/Monsanto deal, (should) be put under the magnifying glass of the committee and the U.S. Department of Justice.”
For all the rhetoric that we often hear about ‘the market’ and large corporations offering choice to farmers and consumers, the evidence is restriction of choice and the squeezing out of competitors. Over the years, for instance, Monsanto has bought up dozens of competitors to become the largest supplier of genetically engineered seeds with seed prices having risen dramatically.
Consolidation and monopoly in any sector should be of concern to everyone. But the fact that the large agribusiness conglomerates specialise in a globalised, industrial-scale, chemical-intensive model of farming that is adversely affecting what we eat should have us very concerned. Do we want this system to be intensified even further just because their business models depend on it?
Farmers are increasingly reliant on patented corporate seeds, whether non-GM hybrid seeds or GM, and the chemical inputs designed to be used with them. Monsanto seed traits are now in 80 per cent of corn and more than 90 per cent of soybeans grown in the US. It comes as little surprise then that people in the US now consume a largely corn-based diet: a less diverse diet than in the past, which is high in calorific value, but low in health-promoting, nutrient dense food. This health-damaging ‘American obesity diet’ and the agricultural practices underpinning is now a global phenomenon.
By its very nature, the capitalist economic model that corporate agriculture is attached to demands expansion, market capture and profit growth. And, it must be accepted that it does bring certain benefits to those farmers who have remained in agriculture (if not for the 330 farmers who leave their land every week, according to data from the National Agricultural Statistics Service).
But in the US, ‘success’ in agriculture depends on over $51 billion of taxpayer handouts to over a 10-year period to keep the gravy train on track for a particular system of agriculture designed to maintain corporate agribusiness profit margins. And such ‘success’ fails to factor in all of the external social, health and environmental costs that mean this type of model is ultimately unsustainable. It is easy to spin failure as success when the parameters are narrowly defined.
Moreover, the exporting of the Green Revolution paradigm throughout the globe has been a boon to transnational seed and agrochemical manufacturers, which have benefited from undermining a healthy, sustainable indigenous agriculture and transforming it into a profitable enterprise for global capital.
And not just profitable for global capital – but its company managers too. For example, a few months ago, according to Reuters, Monsanto CEO Hugh Grant could receive more than $70 million if Monsanto were to be taken over by Bayer. At the time, Monsanto said it was open to engaging in further negotiations with Bayer after turning down its $62 billion bid. The report shows how Grant’s exposure to shares and options meant he had an incentive to hold out for the highest possible sale price, which would not only be in the interests of shareholders but also increase the value of his holdings. Other senior figures within Monsanto would also walk away with massive financial gains.
These corporate managers belong to a global agribusiness sector whose major companies rank among the Fortune 500 corporations. These companies are high-rollers in a geo-politicised, globalised system of food production whereby huge company profits are directly linked to the worldwide eradication of the small farm – the bedrock of global food production, bad food and poor health, inequitable, rigged trade, environmental devastation, mono-cropping and diminished food and diet diversity, the destruction of rural communities, ecocide, degraded soil, water scarcity and drought, destructive and inappropriate models of development and farmers who live a knife-edge existence and for whom debt has become a fact of life.
A handful of powerful and politically connected corporations are determining what is grown, how it is to be grown, what needs to be done to grow it, who grows it and what ends up on the plate. And despite PR platitudes about the GMO/chemical-intensive model just being part of a wider mix of farming practices designed to feed humanity, from India to Africa indigenous models of agriculture are being squeezed out (through false argument and deception) as corporate imperialism puts pay to notions of food sovereignty.
We should be highly concerned about a food system increasingly dominated by companies that have a history (see this on Monsanto and this on Bayer) of releasing health-damaging, environmentally polluting products onto the market and engaging in bribery, cover-ups, monopolistic practices and what should be considered as crimes against humanity?
Despite the likes of Hugh Grant saying the Monsanto-Bayer merger will be good for farmers and “broader society”, most of all it will be good for shareholders and taxpayer-subsidised, state-assisted company profit. That’s the type of hegemonic rhetoric that’s been used down the ages to disguise the true nature of power and its beneficiaries.
It’s not so much the Monsanto-Bayer deal is a move in the wrong direction (which it is), but increasing consolidation is to be expected given the trend in many key sectors toward monopoly capitalism or just plain cartelism, whichever way you choose to look at it. It’s the system of industrialised, capital-intensive agriculture wedded to powerful players whose interests lie in perpetuating and extending their neoliberal economic model that is the real problem.
“We have justified the demise of family farms, decay of rural communities, pollution of the rural environment, and degradation of soil health as being necessary… The problems we are facing today are the consequence of too many people… pursuing their narrow self-interests without considering the consequence of their actions on the rest of society and the future of humanity.” Professor John Ikerd, ‘Healthy Soils, Healthy People
http://www.globalresearch.ca/monsanto-and-bayer-why-food-and-agriculture-just-took-a-turn-for-the-worse/5545791
https://finance.yahoo.com/m/132e8f3f-77b9-3bfb-9621-cb3a76b5ff06/ss_bayer%26%2339%3Bs-monsanto.html
https://finance.yahoo.com/news/bayers-monsanto-acquisition-face-politically-charged-scrutiny-194621252--sector.html
https://finance.yahoo.com/news/bayer-monsanto-used-one-word-121647462.html
https://finance.yahoo.com/news/bayer-signs-deal-worth-close-095924876.html
https://finance.yahoo.com/news/bayer-clinches-monsanto-improved-66-002916208.html
https://finance.yahoo.com/news/bayer-signs-deal-acquire-monsanto-115433013.html
https://finance.yahoo.com/news/bayer-acquire-monsanto-128-share-112050166.html
https://finance.yahoo.com/news/monsanto-board-decide-sale-bayer-tuesday-sources-141518536--finance.html
https://finance.yahoo.com/m/6facbf7a-c02a-328e-ae0b-4d940f422131/ss_bayer-and-monsanto-agree-at.html
https://finance.yahoo.com/m/49a7f135-f706-3d0e-9805-f25790f6165d/ss_bayer-clinches-monsanto-deal.html
https://finance.yahoo.com/news/bayer-clinches-monsanto-improved-66-003658119.html
https://finance.yahoo.com/m/f757bc21-19e4-3fb2-ad60-df384f1c7bd0/ss_bayer-and-monsanto-to-merge.html
https://finance.yahoo.com/news/monsanto-finally-says-yes-to-bayer-herbalife-jumps-on-icahn-comments-wells-fargo-woes-133406577.html
https://finance.yahoo.com/news/bayer-clinches-monsanto-improved-66-billion-bid-002916780--sector.html
https://finance.yahoo.com/news/farmers-worry-monsanto-merger-drive-192356837.html
https://finance.yahoo.com/m/41ea439a-e420-366a-939c-ff57b46d56e9/ss_bayer%2C-monsanto-agree-on-%2466.html
https://finance.yahoo.com/m/650b92b0-a50e-351e-9cbf-cd5858241e38/ss_crops-would-eclipse-drugs-at.html
https://finance.yahoo.com/news/wall-street-no-frills-investment-165600352.html
https://finance.yahoo.com/video/bayer-monsanto-ceos-getting-deal-164521
Charlie Grant (WSJ) nails MON piece: #msg-125162576.
It's About Time: Monsanto Agrees to Bayer Buyout But Will It Happen?
The ongoing soap opera that was the Bayer pursuit of Monsanto (MON) appears to have ended with a $66 billion dollar deal, or $128 a share. Monsanto's stock, however, is still trading near $107. Bernstein's Jonas Oxgaard and team spoke with investors before the deal was made official and offer some insights why that may be: ...we conducted an investor survey with 74 qrespondents in an attempt to gauge the deal's success probability and any other investor sentiment. 80% believe that Monsanto and Bayer will agree to a deal.
https://finance.yahoo.com/news/american-dream-city-living-built-133506175.html
GO MON
"PEACE"
$$$$$$ I'VE GOT MINE $$$$$$
Bayer-MON merger slides:
https://www.advancingtogether.com/en/ir-media/downloads/14th-september-investor-presentation/
No—that can safely be ruled out.
Followers
|
22
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
877
|
Created
|
08/17/06
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |